StockData
MBX Biosciences, Inc. logo

MBX Biosciences, Inc. (MBX) stock

MBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$53.41−0.01 (-0.02%)

Close on Nov 19, 2026Market cap $2.57BP/E –Yield –

MBX Biosciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for MBX Biosciences

MBX Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More MBX Biosciences figures

See a number that looks wrong?